Sequelae of pelvic inflammatory disease
Conditions
Interventions
Control Group:Guizhi Fuling capsule simulator was taken for 12 weeks
Test group:Guizhi Fuling capsule was taken for 12 weeks
Sponsors
The Third Hospital of Peking University
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) According to the diagnostic criteria of Western medicine for sequelae of pelvic inflammatory disease(2)according to the criteria of TCM syndrome differentiation of blood stasis (3)The VAS score of abdominal pain =3 or recurrent attack of previous PID (4)The age ranged from 20 to 50 years (5)21 days = menstrual cycle =35 days (6)The patient gave informed consent and signed the informed consent form
Exclusion criteria
Exclusion criteria: (1)Pelvic inflammatory disease (2) Gynecological tumors (uterine leiomyoma larger than 4 cm in diameter and submucosal leiomyoma) and other related symptoms (3) Ovulation disorders (polycystic ovary syndrome premature ovarian insufficiency congenital gonadal hypoplasia functional ovarian tumor etc.) cervical and uterine body factors (cervical incompetence endometrial lesions uterine tumors uterine adhesions Adenomyosis etc.) (4) Infertility due to non-pelvic inflammatory diseases such as endometriosis and complete obstruction of the fallopian tube (5) Patients with severe primary diseases of heart brain liver kidney hematopoiesis and immune system and psychosis alanine aminotransferase (Alt) aspartate aminotransferase (AST) were more than 2 times of the upper limit of the normal value serum creatinine (CR) were more than the upper limit of the normal value (6)Anaphylaxis was defined as people who were allergic to three or more foods (7) Participated in other clinical studies within 1 month before screening (8)Were not considered suitable by the investigators to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in VAS scores of lower abdominal pain;PID recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first recurrence of PID;Pregnancy rate;Pelvic inflammatory masses effusion improvement rate;Blood stasis syndrome effective rate;The change of pelvic sign grading score; | — |
Countries
China
Contacts
Public ContactRong Li
The Third Hospital of Peking University
Outcome results
None listed